Effects of glycopyrrolate premedication on preventing postoperative catheter-related bladder discomfort in patients receiving ureteroscopic removal of ureter stone

다국어 초록 (Multilingual Abstract)

Background: Glycopyrrolate given as reversing agents of muscle relaxants has been reported to be effective in reducing postoperative catheter-related bladder discomfort (CRBD). However, it remains unclear whether glycopyrrolate as premedication is also effective. This study aims to investigate the effectiveness of glycopyrrolate as premedication on preventing CRBD in the post-anesthesia care unit (PACU).
Methods: Eighty-three patients who received elective ureteroscopic removal of ureteral stone were randomly assigned to the control (n = 43) or the glycopyrrolate group (n = 40). The glycopyrrolate group was treated with glycopyrrolate 0.3 mg as premedication while the control group received 0.9% saline 1.5 ml. The incidence and severity of CRBD and pain score using numerical rating scale (NRS) were measured in the PACU.
Results: The incidence of CRBD (26 of 40 patients vs. 41 of 43 patients, relative risk [RR] = 0.68, 95% Confidence interval [CI] = 0.53–0.86, P = 0.001) and the moderate to severe CRBD incidence (6 of 40 patients vs. 20 of 43 patients, RR = 0.32, 95% CI = 0.14–0.72, P = 0.002) were lower in the glycopyrrolate group than in the control group. Also, postoperative pain NRS score was found to be lower in the glycopyrrolate group (median = 1 [Q1 = 0, Q3 = 2]) compared to the control group (3 [1, 5], median difference = 1.00, 95% CI = 0.00–2.00, P = 0.002).
Conclusions: The use of glycopyrrolate 0.3 mg as premedication in patients receiving ureteroscopic removal of ureteral stone reduced the incidence and severity of CRBD, and decreased postoperative pain in the PACU.

참고문헌 (Reference)

1 Agarwal A, "The efficacy of tolterodine for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study" 101 : 1065-1067, 2005

2 Ryan PC, "The effects of acute and chronic JJ stent placement on upper urinary tract motility and calculus transit" 74 : 434-439, 1994

3 Kim HC, "The effect of sevoflurane versus desflurane on postoperative catheter-related bladder discomfort in patients undergoing transurethral excision of a bladder tumour: a randomized controlled trial" 63 : 596-602, 2016

4 Kim HC, "The effect of intraoperative dexmedetomidine on postoperative catheter-related bladder discomfort in patients undergoing transurethral bladder tumour resection: a double-blind randomised study" 32 : 596-601, 2015

5 Guard BC, "The effect of glycopyrrolate on postoperative pain and analgesic requirements following laparoscopic sterilisation" 51 : 1173-1175, 1996

6 Tauzin-Fin P, "Sublingual oxybutynin reduces postoperative pain related to indwelling bladder catheter after radical retropubic prostatectomy" 99 : 572-575, 2007

7 Eglen RM, "Selective muscarinic receptor agonists and antagonists" 78 : 59-68, 1996

8 Srivastava A, "Routine stenting after ureteroscopy for distal ureteral calculi is unnecessary: results of a randomized controlled trial" 17 : 871-874, 2003

9 Kim HC, "Postanaesthetic emergence agitation in adult patients after general anaesthesia for urological surgery" 43 : 226-235, 2015

10 Haddad EB, "Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways" 127 : 413-420, 1999

11 Chess-Williams R, "Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional" 22 : 133-145, 2002

12 Eglen RM, "Muscarinic receptor subtypes and smooth muscle function" 48 : 531-565, 1996

13 Agarwal A, "Ketamine for treatment of catheter related bladder discomfort: a prospective, randomized, placebo controlled and double blind study" 96 : 587-589, 2006

14 Agarwal A, "Evaluation of intra-operative tramadol for prevention of catheter-related bladder discomfort: a prospective, randomized, double-blind study" 101 : 506-510, 2008

15 Lepousé C, "Emergence delirium in adults in the post-anaesthesia care unit" 96 : 747-753, 2006

16 Bala I, "Efficacy of gabapentin for prevention of postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor" 79 : 853-857, 2012

17 Ryu JH, "Efficacy of butylscopolamine for the treatment of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study" 111 : 932-937, 2013

18 Kim HC, "Effect of glycopyrrolate versus atropine coadministered with neostigmine for reversal of rocuronium on postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: a prospective randomized study" 29 : 831-835, 2015

19 Guenther U, "Delirium in the postanaesthesia period" 24 : 670-675, 2011

20 Ramsay MA, "Controlled sedation with alphaxalone-alphadolone" 2 : 656-659, 1974

21 Agarwal A, "Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study" 96 : 377-380, 2006

22 Agarwal A, "An evaluation of the efficacy of gabapentin for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study" 105 : 1454-1457, 2007

23 Cheung MC, "A prospective randomized controlled trial on ureteral stenting after ureteroscopic holmium laser lithotripsy" 169 : 1257-1260, 2003

24 Campos JH, "A comparison of a left-sided Broncho-Cath with the torque control blocker univent and the wire-guided blocker" 96 : 283-289, 2003